EAM Investors’s Globus Medical GMED Stock Holding History

EAM Investors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,305	Closed	-$1.63M	–	312
2021 Q3	$1.63M	Buy	+21,305	New	+$1.71M	0.28%	173
2021 Q1	–	Sell	-31,233	Closed	-$2.04M	–	378
2020 Q4	$2.04M	Buy	+31,233	New	+$1.8M	0.33%	111
2018 Q3	–	Sell	-48,380	Closed	-$2.44M	–	332
2018 Q2	$2.44M	Sell	48,380 -15,178	-24%	-$791K	0.38%	132
2018 Q1	$3.17M	Buy	63,558 +4,975	+8%	+$234K	0.53%	65
2017 Q4	$2.41M	Buy	+58,583	New	+$2.05M	0.43%	99
2017 Q3	–	Sell	-82,070	Closed	-$2.72M	–	308
2017 Q2	$2.72M	Buy	+82,070	New	+$2.58M	0.45%	99
2014 Q3	–	Sell	-60,755	Closed	-$1.45M	–	330
2014 Q2	$1.45M	Sell	60,755 -19,953	-25%	-$481K	0.28%	159
2014 Q1	$2.15M	Buy	80,708 +18,480	+30%	+$439K	0.39%	77
2013 Q4	$1.26M	Buy	62,228 +5,110	+9%	+$94.9K	0.22%	240
2013 Q3	$997K	Sell	57,118 -5,061	-8%	-$87.6K	0.2%	271
2013 Q2	$1.05M	Buy	+62,179	New	+$960K	0.23%	209

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EAM Investors's GMED Position: Q4 2021 in Review

EAM Investors sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 21,305 shares — an estimated $1.63M sold.

EAM Investors first reported a position in GMED in Q2 2013 and held it in 11 quarters. The position peaked at $3.17M in Q1 2018. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

EAM Investors reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
EAM Investors sold 21,305 Globus Medical shares in Q4 2021, an estimated $1.63M.
EAM Investors first reported a position in Globus Medical in Q2 2013 and held it in 11 quarters.
EAM Investors's Globus Medical position peaked at $3.17M in Q1 2018.
373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.